01.11.2018 | Case report
Ledipasvir/sofosbuvir/ribavirin
Development of drug resistance: case report
Erschienen in: Reactions Weekly | Ausgabe 1/2018
Einloggen, um Zugang zu erhaltenExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event